ClinicalTrialsFinder

Advanced Gastroesophageal Junction Cancer Clinical Trials in GangnamGu, Seoul Teugbyeolsi

1 recruitingGangnamGu, Seoul Teugbyeolsi, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Advanced Gastric CancerMetastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung Cancer+4 more
BeiGene514 enrolled17 locationsNCT06585488